(Q42260265)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24154737%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Compromised function of natural killer cells in acute and chronic viral hepatitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24154737%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24154737%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Niklas K. Björkström

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24154737%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

David F G Malone

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24154737%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Markus Cornberg

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24154737%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

11

Michael P Manns

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24154737%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

15

Heiner Wedemeyer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24154737%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1

Sebastian Lunemann

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24154737%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Julia Hengst

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24154737%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Kerstin Port

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24154737%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Jan Grabowski

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24154737%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Katja Deterding

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24154737%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Antoaneta Markova

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24154737%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Birgit Bremer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24154737%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Verena Schlaphoff

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24154737%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Hans-Gustaf Ljunggren

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24154737%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

language of work or name

English

0 references

publication date

23 October 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24154737%20AND%20SRC:MED&resulttype=core&format=json

Journal of Infectious Diseases

28 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24154737%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

209

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24154737%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24154737%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

1362-1373

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24154737%20AND%20SRC:MED&resulttype=core&format=json

Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Living in the liver: hepatic infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

The host-pathogen interaction during HBV infection: immunological controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

New insight in the pathobiology of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

T cell responses in hepatitis C: the good, the bad and the unconventional

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Hepatitis delta: immunopathogenesis and clinical challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Organ-specific features of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Molecular mechanisms of natural killer cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Activation of natural killer cells during acute infection with hepatitis C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Phenotypic and Functional Changes of Cytotoxic CD56pos Natural T Cells Determine Outcome of Acute Hepatitis C Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Temporal analysis of early immune responses in patients with acute hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Natural killer cell function is intact after direct exposure to infectious hepatitis C virions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Natural killer cells: primary target for hepatitis C virus immune evasion strategies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Natural killer cells in viral hepatitis: facts and controversies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Reduced frequencies of NKp30+NKp46+, CD161+, and NKG2D+ NK cells in acute HCV infection may predict viral clearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Influence of HBV replication and delta agent superinfection on T cell subsets and killer (Leu 7+) in chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Natural killer response to exogenous interferon in delta hepatitis: boost or depression defined within the first week of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

Characterization of natural killer cell phenotype and function during recurrent human HSV-2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT561

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIT561

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24154737%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference